2018
DOI: 10.5812/pedinfect.12236
|View full text |Cite
|
Sign up to set email alerts
|

Staphylococcus and Linezolid Resistance in Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…Although in our study the lowest resistance was observed to linezolid (22.7%), this rate of resistance was high in comparison with many studies in Iran and other countries [23,28,29,30]. According to multinational and multicenter surveillance studies, more than 99% of coagulase-negative staphylococci and S. aureus clinical strains are sensitive to linezolid (31) [31]. The common mechanisms for linezolid resistance are mutations in the linezolid 23S rRNA binding site and acquisition of a plasmid-borne ribosomal methyltransferase gene called the cfr (chloramphenicol/florfenicol resistance) gene.…”
Section: Discussionmentioning
confidence: 48%
“…Although in our study the lowest resistance was observed to linezolid (22.7%), this rate of resistance was high in comparison with many studies in Iran and other countries [23,28,29,30]. According to multinational and multicenter surveillance studies, more than 99% of coagulase-negative staphylococci and S. aureus clinical strains are sensitive to linezolid (31) [31]. The common mechanisms for linezolid resistance are mutations in the linezolid 23S rRNA binding site and acquisition of a plasmid-borne ribosomal methyltransferase gene called the cfr (chloramphenicol/florfenicol resistance) gene.…”
Section: Discussionmentioning
confidence: 48%
“…The published reports of infections due to LRSA strains between the years 2001 and 2011 in different parts of world indicate a prevalence of 0.05% [31]. In studies conducted in different geographic areas of Iran, the LRSA strains have not been documented, except studies conducted in Tabriz and Mashhad [32]. Isolation of LRSA strains from important clinical specimens such as burn wound infection and diabetic foot ulcer, can be a serious threat due to the spread of these resistant strains in the hospitals.…”
Section: Discussionmentioning
confidence: 99%
“…Linezolid is effective against more than 98% of Staphylococcus infections, with resistance detected in only 0.05% of S. aureus infections. In many studies conducted in Iran, resistance to linezolid was either not reported or was very low (25). Studies analyzing the resistance of Staphylococcus isolates to linezolid in various countries found that the United States, Canada, and European countries had higher levels of resistance, while African and Asian countries reported the lowest (0.1%) resistance among MRSA strains (26).…”
Section: Discussionmentioning
confidence: 99%